Adaptive Biotechnologies director Katey Einterz Owen sells 9,615 shares for $249,990

Bitget

News

Reuters2026/08/28 21:50

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Adaptive Biotechnologies director Katey Einterz Owen sold 9,615 common shares on Aug. 26, 2026 at USD 26.
Directly held stake fell to 78,639 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001852578-26-000005), on August 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Adaptive Biotechnologies director Katey Einterz Owen sells 9,615 shares for $249,990

You may also like

Crypto prices